Associated Papers
A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor.
Němejcová K et al.
Virchows Archiv : an International Journal of Pathology, 2025
39592485 (PubMed )
Supplement: 428_2024_3984_MOESM3_ESM.xlsx › all_detected_pathogenic_m.
DICER1 Mutational Spectrum in Intracranial CNS-Neoplasias-A Review and a Report from the CNS-InterREST GPOH Study Center.
Manea S et al.
Cancers, 2025
40361440 (PubMed )
Supplement: cancers-17-01513-s001.zip › cancers-3488083-supplementary.xlsx › Blatt_1_-_Tabelle_1
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Li BK et al.
Acta Neuropathologica, 2020
DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN et al.
The American Journal of Surgical Pathology, 2019
DICER1 gene mutations in endocrine tumors.
Solarski M et al.
Endocrine-related Cancer, 2018
DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center.
van Engelen K et al.
Pediatric Blood & Cancer, 2018
Germ-line and somatic DICER1 mutations in pineoblastoma.
de Kock L et al.
Acta Neuropathologica, 2014
Select a paper to view details